Symptomatic treatment of migraine: When to use NSAIDs, triptans, or opiates

Current Treatment Options in Neurology

Volumn 13, Issue 1, 2011, Pages 15-27

  Taylor, Frederick R ^a   Kaniecki, Robert G ^b  

^a Park Nicollet Headache Clinic   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; BUTALBITAL; DICLOFENAC; DICLOFENAC POTASSIUM; DIHYDROERGOTAMINE; ELETRIPTAN; FROVATRIPTAN; IBUPROFEN; KETOPROFEN; KETOROLAC TROMETAMOL; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PIROXICAM; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; TOLFENAMIC ACID; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ABDOMINAL DISCOMFORT; ARTICLE; ASTHENIA; BURNING SENSATION; CHEST TIGHTNESS; COMBINATION CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; HEADACHE; HOT FLUSH; HUMAN; HYPERALGESIA; INJECTION SITE REACTION; MENTAL DISEASE; MIGRAINE; MONOTHERAPY; MYALGIA; NONHUMAN; PARESTHESIA; PATIENT ASSESSMENT; PRURITUS; RASH; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SKIN BRUISING; SKIN SENSITIVITY; TASTE DISORDER; THROAT TIGHTNESS; TREATMENT OUTCOME;

EID: 79551573139     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-010-0107-4     Document Type: Article

References (53)

1. A Charles KC Brennan 2010 The neurobiology of migraine Handb Clin Neurol 97 99 108 10.1016/S0072-9752(10)97007-3 20816413 This is an up-to-date review of migraine neurobiology.
2. PJ Goadsby 2007 Recent advances in understanding migraine mechanisms, molecules and therapeutics Trends Mol Med 13 39 44 1:CAS:528: DC%2BD2sXis1Crtw%3D%3D 10.1016/j.molmed.2006.11.005 17141570 (Pubitemid 46027728)
3. R Noseda V Kainz M Jakubowski, et al. 2010 A neural mechanism for exacerbation of headache by light Nature Neuroscience. 13 239 245 1:CAS:528:DC%2BC3cXjsVejuw%3D%3D 10.1038/nn.2475 20062053
4. D Levy R Burstein AM Strassman 2005 Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine Ann Neurol. 58 698 705 1:CAS:528:DC%2BD2MXht1Cgu73K 10.1002/ana.20619 16240341 (Pubitemid 41552545)
5. XC Zhang AM Strassman R Burstein D Levy 2007 Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators J Pharmacol Exp Ther. 322 806 812 1:CAS:528:DC%2BD2sXoslSju7w%3D 10.1124/jpet.107.123745 17483291 (Pubitemid 47105821)
6. R Burstein M Jakubowski 2010 Managing migraine associated with sensitization Handb Clin Neurol 97 207 215 10.1016/S0072-9752(10)97016-4 20816422 This is an important review of the literature regarding treatment of neuronal sensitization in migraine.
7. KA Petersen S Birk LH Lassen, et al. 2005 The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers Cephalalgia. 25 139 147 1:STN:280:DC%2BD2M%2Fjt1Kktw%3D%3D 10.1111/j.1468-2982. 2004.00830.x 15658951 (Pubitemid 40193957)
8. M Maizels R Burchette 2003 Rapid and sensitive paradigm for screening patients with headache in primary care settings Headache 43 441 50 10.1046/j.1526-4610.2003.03088.x 12752748 (Pubitemid 36554657)
9. AJ Dowson S Lipscombe J Sender, et al. 2002 New guidelines for the management of migraine in primary care Curr Med Res Opin 18 414 39 1:STN:280:DC%2BD38jisVyntQ%3D%3D 10.1185/030079902125001164 12487508 (Pubitemid 35448539)
10. RK Cady FG Freitag NT Mathew, et al. 2009 Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention Headache. 49 350 363 10.1111/j.1526-4610.2009.01340.x 19220503
11. HC Diener DW Dodick PJ Goadsby, et al. 2008 Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database Cephalalgia. 28 35 40 10.1111/j.1468-2982.2008.01660.x 17941878
12. V Snow K Weiss E Wall C Mottur-Pilson 2002 American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache Ann Int Med 137 840 852 1:CAS:528:DC%2BD38Xptlajur0%3D 12435222
13. SD Silberstein 2000 Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 754 62 1:CAS:528:DC%2BD3cXntlygsLg%3D 10993991
14. E Loder 2010 Triptan Therapy in migraine N Engl J Med 363 63 70 1:CAS:528:DC%2BC3cXpslyjtrs%3D 10.1056/NEJMct0910887 20592298 This is the most up-to-date review on triptans.
15. AM Rapoport SJ Tepper ME Bigal FD Sheftell 2003 The triptan formulations: how to match patients and products CNS Drugs 17 431 447 1:CAS:528: DC%2BD3sXksVagsr4%3D 10.2165/00023210-200317060-00005 12697002 (Pubitemid 36560705)
16. FR Taylor 2010 Acute treatment of migraine headaches Semin Neurol 30 145 153 10.1055/s-0030-1249223 20352584 This review presents the lead author's opinion about acute therapy, to complement this article.
17. D Levy M Jakubowski R Burstein 2004 Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists Proc Natl Acad Sci USA 101 4274 4279 1:CAS:528:DC%2BD2cXivFartLY%3D 10.1073/pnas.0306147101 15016917 (Pubitemid 38405919)
18. KG Shields PJ Goadsby 2006 Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? Neurobiol Dis 23 491 501 1:CAS:528:DC%2BD28XotlWnsL0%3D 10.1016/j.nbd.2006.04. 003 16875831 (Pubitemid 44234086)
19. T Bartsch YE Knight PJ Goadsby 2004 Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception Ann Neurol 56 371 381 1:CAS:528:DC%2BD2cXotFyhs70%3D 10.1002/ana.20193 15349864 (Pubitemid 39166556)
20. D Dodick RB Lipton V Martin, et al. 2004 Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine Headache 44 414 425 10.1111/j.1526-4610.2004.04078.x 15147249 (Pubitemid 38685549)
21. RW Evans SJ Tepper RE Shapiro, et al. 2010 The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper Headache 50 1089 1099 10.1111/j.1526-4610.2010. 01691.x 20618823 This is an important position paper on serotonin syndrome and triptans by the American Headache Society.
22. S Diamond ME Bigal S Silberstein, et al. 2007 Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study Headache 47 355 363 17371352
23. C Whyte SJ Tepper RW Evans 2010 Expert Opinion: Rescue Me: Rescue Medication for Migraine Headache 50 307 313 10.1111/j.1526-4610.2009.01597.x 20456134
24. S Landy 2004 Migraine throughout the life cycle. Treatment through the ages Neurology 62 Suppl.2 S2 S8 1:CAS:528:DC%2BD2cXivVWjuro%3D 15007158
25. RB Lipton B Grosberg RP Singer, et al. 2010 Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT) Cephalalgia 30 1336 45 10.1177/ 0333102410367523 20959428
26. V Limmroth Z Katsarava HC Diener 1999 Acetylsalicylic acid in the treatment of headache Cephalalgia 19 545 551 1:STN:280:DyaK1MznslKnuw%3D%3D 10.1046/j.1468-2982.1999.019006545.x 10448540 (Pubitemid 29362808)
27. CC Suthisisang N Poolsup N Suksomboon, et al. 2010 Meta-Analysis of the Efficacy and Safety of Naproxen Sodium in the Acute Treatment of Migraine Headache 50 808 818 10.1111/j.1526-4610.2010.01635.x 20236345
28. RB Lipton J Goldstein JS Baggish, et al. 2005 Aspirin is efficacious for the treatment of acute migraine Headache 45 283 292 10.1111/j.1526-4610.2005. 05065.x 15836564 (Pubitemid 40530192)
29. C Lampl M Voelker HC Diener 2007 Efficacy and safety of 1000 mg effervescent aspirin: Individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms J Neurol 254 705 712 1:CAS:528:DC%2BD2sXovFait7w%3D 10.1007/s00415-007-0547-2 17406776 (Pubitemid 47012463)
30. F Boureau JM Joubert V Lasserre, et al. 1994 Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in an acute migraine attack Cephalalgia 14 156 161 1:STN:280: DyaK2czktVKqtA%3D%3D 10.1046/j.1468-2982.1994.1402156.x 8062355 (Pubitemid 24146151)
31. GN Volans 1975 The effect of metoclopramide on the absorption of effervescent aspirin in migraine Br J Clin Pharmacol 2 57 63 1:CAS:528:DyaE28XhsF2rsrc%3D 791318
32. P Tfelt-Hansen J Olesen 1984 Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: A doubleblind study Cephalalgia 4 107 111 1:STN:280:DyaL2c3jtl2rsw%3D%3D 10.1046/j.1468-2982.1984.0402107.x 6375873
33. C Suthisisang N Poolsup W Kittikulsuth, et al. 2007 Efficacy of low-dose ibuprofen in acute migraine treatment: Systematic review and meta-analysis Ann Pharmacother 41 1782 1791 1:CAS:528:DC%2BD2sXhtlGrtb7P 10.1345/aph.1K121 17878396 (Pubitemid 350044339)
34. JR Codispoti MJ Prior M Fu, et al. 2001 Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial Headache 41 665 679 1:STN:280:DC%2BD3MrgsFOisA%3D%3D 10.1046/j.1526-4610.2001. 041007665.x 11554954 (Pubitemid 32777749)
35. VV Myllylä H Havanka L Herrala, et al. 1998 Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel group study Headache 38 201 207 10.1046/j.1526-4610.1998.3803201.x 9563211
36. RA Tokola P Kangasniemi PJ Neuvonen O Tokola 1984 Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks Cephalalgia 4 253 263 1:STN:280:DyaL2M%2FpvFaqsQ%3D%3D 10.1046/j.1468-2982.1984.0404253.x 6394143
37. S Konduri J Colon CH Baker S Safe JL Abbruzzese A Abudayyeh MR Basha M Abdelrahim 2009 Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by survivin protein expression Mol Cancer Ther 8 533 542 1:CAS:528:DC%2BD1MXjtVyjsLg%3D 10.1158/1535-7163.MCT-08-0405 19258429
38. The Diclofenac-K/Sumatriptan Migraine Study Group 1999 Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo Cephalalgia 19 232 240 10.1046/j.1468-2982.1999.019004232.x (Pubitemid 29268496)
39. C Dahlof R Bjorkman 1993 Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine Cephalalgia 13 117 123 1:STN:280: DyaK3s3msFGhtA%3D%3D 10.1046/j.1468-2982.1993.1302117.x 8495453 (Pubitemid 23116123)
40. SJ Peroutka JA Lyon J Swarbrick, et al. 2004 Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study Headache. 44 136 141 10.1111/j.1526-4610.2004.04029.x 14756851 (Pubitemid 38233755)
41. G Nappi G Micieli C Tassorelli, et al. 1993 Effectiveness of a piroxicam fast dissolving formulation sublingually administered in the symptomatic treatment of migraine without aura Headache 33 296 300 1:STN:280: DyaK3szlt1aqtw%3D%3D 10.1111/j.1526-4610.1993.hed3306296.x 8349471
42. M Dib H Massiou M Weber, et al. 2002 Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial Neurology 58 1660 1665 1:CAS:528:DC%2BD38XltFSntb8%3D 12058095
43. JT Meredith S Wait KL Brewer 2003 A prospective double-blind study of nasal sumatriptan versus ketorolac in migraine Am J Emerg Med 21 173 175 10.1016/S0735-6757(02)42256-5 12811706 (Pubitemid 36734676)
44. LJ Turkewitz JS Casaly GA Dawson, et al. 1992 Self-administration of parenteral ketorolac tromethamine for head pain Headache 32 452 454 1:STN:280:DyaK3s%2Fnslalug%3D%3D 10.1111/j.1526-4610.1992.hed3209452.x 1446989
45. JA Klapper JS Stanton 1991 Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches Headache 31 523 524 1:STN:280: DyaK38%2FntFWntQ%3D%3D 10.1111/j.1526-4610.1991.hed3108523.x 1960056
46. SD Silberstein DC McCrory 2001 Butalbital in the treatment of headache: History, pharmacology, and efficacy Headache 41 953 967 1:STN:280: DC%2BD387mvFymtg%3D%3D 10.1046/j.1526-4610.2001.01189.x 11903523 (Pubitemid 34008131)
47. RW Evans SM Baskin 2010 Why do migraineurs abuse butalbital-containing combination analgesics? Headache 50 1194 1197 10.1111/j.1526-4610.2010.01725.x 20649651
48. M Jakubowski D Levy I Goor-Aryeh, et al. 2005 Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors Headache. 45 850 861 10.1111/j.1526-4610.2005.05153.x 15985101 (Pubitemid 41045361)
49. ME Bigal RB Lipton 2009 Excessive opioid use and the development of chronic migraine Pain 142 179 182 1:CAS:528:DC%2BD1MXjtF2jsLo%3D 10.1016/j.pain.2009.01.013 19232469 This article is of major importance regarding issues of opioids in migraine.
50. ME Bigal D Serrano D Buse ET AL 2008 Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study Headache 48 1157 1168 10.1111/j.1526-4610.2008.01217.x 18808500
51. SD Silberstein 2005 Clinical practice guidelines Cephalalgia 25 765 766 1:STN:280:DC%2BD2MvptFGqsQ%3D%3D 10.1111/j.1468-2982.2005.01014.x 16162252 (Pubitemid 41368670)
52. JR Saper AE Lake RL Hamel, et al. 2004 Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program Neurology 62 1687 1694 1:STN:280:DC%2BD2c3mtVarsA%3D%3D 15159463
53. JR Saper AE Lake PA Bain, et al. 2010 A practice guide for continuous opioid therapy for refractory daily headache: Patient selection, physician requirements, and treatment monitoring Headache 50 1175 1193 10.1111/j.1526-4610.2010.01733.x 20649650